Clinical trial
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
NCT00288444 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00288444 |
|---|---|
| Title | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer |
| Official title | Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies |
| Lead sponsor | Emory University, Other |
| Collaborators | Aventis Pharmaceuticals Industry Schering-Plough |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Soft Tissue Sarcoma, Colorectal Carcinoma, Breast Cancer, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Lonafarnib, Docetaxel |
| Enrollment | 38 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Feb 8, 2006 |
| Last update posted | Dec 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: